Diagnostics Pipeline: 2024 Trends in FDA Approvals
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
Clinical Diagnostics Insider
(formerly Diagnostic Testing and Emerging Technologies)
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
A Closer Lab-Patient Connection
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
New and Improved: The Latest Research in Disease Screening
New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes
New Study Supports Use of Liquid Biopsy Technology to Bolster MRI Accuracy in Cancer Treatment
...
Already a member? Log in here
The Evolving COVID-19 Market: FDA Clears the Way for Asymptomatic Screening Products
...
Already a member? Log in here
Tests with EUA
...
Already a member? Log in here
2020 Was a Record Year for New Medical Device Approvals—And Not Just for COVID-19
...
Already a member? Log in here
